Recombinant Human B7-H3/CD276 (C-6His)

Artikelnummer: ABI-32-8630-10
Artikelname: Recombinant Human B7-H3/CD276 (C-6His)
Artikelnummer: ABI-32-8630-10
Hersteller Artikelnummer: 32-8630-10
Alternativnummer: ABI-32-8630-10-10UG
Hersteller: Abeomics
Kategorie: Proteine/Peptide
Source: Human Cells. MW :47.3kD. Recombinant Human B7 Homolog 3 is produced by our Mammalian expression system and the target gene encoding Leu29-Thr461 is expressed with a 6His tag at the C-terminus. CD276, also known as B7-H3, is a member of the B7 superfamily with signature IgV and IgG regions in extracellular domains. It is a type I transmembrane protein and shares 20a€''27% amino acid identity with other B7 family members. B7-H3 is involved in the activation of T lymphocytes, and regulates murine bone formation. It is also reported that B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. B7-H3 is expressed on T-cells, natural killer cells, and antigen presenting cells, as well as some non-immune cells, such as osteoblasts, fibroblasts, fibroblast-like synoviocytes and epithelial cells. High expression of B7-H3 in tumor vasculature also correlates with poor survival in patients, suggesting that it may play a role in tumor cell migration.
NCBI: 80381
UniProt: Q5ZPR3
Antibody Type: Recombinant Antibody
Application Verdünnung: Endotoxin : Less than 0.1 ng/µg (1 IEU/µg) as determined by LAL test.